Man Hospitalized for Injecting Semen Into Himself. Discharged Prematurely From Hospital.
An interesting case has cum—come--out of Dublin, Ireland recently when it was discovered that a 33-year-old man was taken to the hospital and treated for having repeatedly injected himself in the arm with his own semen for over a year in a strange attempt to treat pain in his lower-back. Everyone knows that’s not where you inject semen!
The patient took it upon himself to devise this ‘cure’ without consulting a medical professional. He informed medical practitioners that he had injected himself with a monthly “dose” of semen with a hypodermic needle he bought online for 18 consecutive months. Must have been some back pain. I hope he at least enjoyed it.
WJLA reports that the man developed a subcutaneous abscess on his right arm where an excess of liquid was forming under his skin. He was treated with an IV of antimicrobial drip, but discharged himself prematurely and didn’t allow the ‘local collection’ to be drained.
The case was published in an Irish Medial Journal and was titled ‘Semenly’ Harmless Back Pain: An Unusual Presentation of a Subcutaneous Abscess.
The case shares:
A physical examination of his upper and lower limbs identified a small, red papule on his right arm. He disclosed at this stage that he had been injecting his own semen as an “innovative” method of treating back pain.
It is the first case of “intravenous semen injection” found in any medical publication.
Although there is a report of the effects of subcutaneous semen injection into rats and rabbits, there were no cases of intravenous semen injection into humans found across the literature. A search of more eclectic internet sites and forums found no other documentation of semen injection for back pain treatment or other uses.
—let’s hope this isn’t a trend.
ABC shared more from the report:
The dangers of venepuncture when carried out by the untrained layperson are highlighted as well as the vascular and soft tissue hazards surrounding the attempted injection of substances not intended for intravenous use. The case also demonstrates the risks involved with medical experimentation prior to extensive clinical research in the form of phased trials inclusive of safety and efficacy assessments.
Please don’t try this at home.